Dr Lal Pathlabs

LALPATHLAB30 Apr 2024
Healthcare
₹
+25.50 (+1.09%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Dr Lal Pathlabs
Dr Lal Pathlabs
Healthcare
LALPATHLAB30 Apr 2024
₹
+25.50 (+1.09%)
OverviewFundamentalsFuturesOptions
1D
1M
6M
1Y
5Y
All

Dr Lal Pathlabs - Share Price & Details

Lowest Today
2353.2
Highest Today
2379.65
Today’s Open
2366.8
Prev. Close
2346.95
52 Week High
2767.1
52 Week Low
1888.1
Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
21.27%
Upper Circuit
Lower Circuit
P/E TTM
54.07
P/B Ratio
10.94
Traded Value(Cr)
0.00
EPS TTM
43.88
Book value
Dividend
0.25%

Price Performance

5.47 %
1 Wk
3.68 %
1 M
-4.19 %
3 M
21.27 %
1 Y
-7.88 %
YTD

Traded Volume Movement

Technical Details

Support 3
2331
Support 2
2342
Support 1
2358
Pivot Point :
2369
Resistance 1
2384
Resistance 2
2395
Resistance 3
2411

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Dr Lal Pathlabs Ltd
₹2,372.45(+25.50/1.09%)
2,372.45+25.5019,804.7021.2754.0710.94
Shalby Ltd
₹277.30(-1.50/-0.54%)
277.30-1.502,995.1192.4430.082.95
Fortis Healthcare Ltd
₹438.55(-4.50/-1.02%)
438.55-4.5033,108.6968.22433.863.68
Poly Medicure Ltd
₹1,643.20(+2.20/0.13%)
1,643.20+2.2015,770.0266.9965.9811.88
Mohini Health & Hygiene Ltd
₹56.25(-2.55/-4.34%)
56.25-2.55102.584.2615.001.14
GPT Healthcare Ltd
₹172.25(-0.30/-0.17%)
172.25-0.301,413.390.0028.976.63

About Dr Lal Pathlabs Ltd

Dr Lal Pathlabs Ltd is in the Healthcare sector, having a market capitalization of Rs. 19804.29 crores. It has reported a sales of Rs. 476 crores and a net profit of Rs. 88.3 crores for the quarter ended December 2018. The company management includes Arvind Lal, Arvind Lal,Vandana Lal,Archana Lal Erdmann,Om Prakash Manchanda,Rahul Sharma,Anoop Mahendra Singh,Harneet Singh Chandhoke,Sunil Varma,Saurabh Srivastava,Somya Satsangi,Rohit Bhasin,Arun Duggal,Gurinder Singh Kalra,RAJIT MEHTA (Dr Lal Pathlabs Ltd) among others.
Chairman
Arvind Lal
Registered office
E-2 Block Sector 18,Rohini,New Delhi,New Delhi,110085
FAX :91-011-2788 2134
Background
Incorporation Year1995
Face Value₹10
Market Lot1

Latest News

General Elections 2024: Will Nifty50 extend gains for 4th month in May?
With the general elections 2024 ongoing and the hopes of the incumbent PM Modi retaining office for the third term, Indian markets are likely to extend gains, giving positive returns for the fourth straight month in May. Moreover, improved macro data, continued foreign investor inflows, decent March quarter earnings and overall positive global trends will also aid investor sentiment this month.
01 May 2024 | 11:10 AM
Mold Tek Tech Standalone March 2024 Net Sales at Rs 39.09 crore
Reported Standalone quarterly numbers for Mold Tek Technologies are: Net Sales at Rs 39.09 crore in March 2024 up 0.47% from Rs. 38.90 crore in March 2023. Quarterly Net Profit at Rs. 6.43 crore in March 2024 down 36.14% from Rs. 10.06 crore in March 2023. EBITDA stands at Rs. 10.18 crore in March 2024 down 30.42% from Rs. 14.63 crore in March 2023.
01 May 2024 | 11:37 AM
Foseco India Standalone March 2024 Net Sales at Rs 122.55 crore
Reported Standalone quarterly numbers for Foseco India are: Net Sales at Rs 122.55 crore in March 2024 up 10.46% from Rs. 110.95 crore in March 2023. Quarterly Net Profit at Rs. 15.85 crore in March 2024 up 11.31% from Rs. 14.24 crore in March 2023. EBITDA stands at Rs. 23.46 crore in March 2024 up 13.33% from Rs. 20.70 crore in March 2023. EPS has increased to Rs. 24.81 in March 2024.
01 May 2024 | 11:36 AM
Chola Invest. Consolidated March 2024 Net Sales at Rs 5,427.56 crore
Reported Consolidated quarterly numbers for Cholamandalam Investment and Finance Company are: Net Sales at Rs 5,427.56 crore in March 2024 up 45.08% from Rs. 3,741.11 crore in March 2023. Quarterly Net Profit at Rs. 1,065.23 crore in March 2024 up 24.56% from Rs. 855.20 crore in March 2023. EBITDA stands at Rs. 4,082.54 crore in March 2024 up 39.23% from Rs. 2,932.26 crore in March 2023.
01 May 2024 | 11:35 AM
Indus Towers Q4 Results | Profit jumps 33% to ₹1,853 crore
Telecom infrastructure major Indus Towers Ltd on Tuesday (April 30) reported a 32.5% year-on-year (YoY) increase in net profit at ₹1,853.1 crore for the fourth quarter that ended March 31, 2024. In the corresponding quarter, Indus Towers posted a net profit of ₹1,399.1 crore, the company said in a regulatory filing. The company's revenue from operations increased 6.5% to ₹7,193.2 crore.
01 May 2024 | 11:33 AM
view more news

How to buy Dr Lal Pathlabs shares on nse?

To buy Dr Lal Pathlabs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Dr Lal Pathlabs share price today?

The Dr Lal Pathlabs shares price on nse is Rs.2372.45 today.

What is the market cap of Dr Lal Pathlabs shares on NSE ?

The company has a market capitalization of Rs.19804.70Cr

What is the PE & PB ratio of Dr Lal Pathlabs shares ?

PE is 54.07 and PB is 10.94

What is the 52 Week High and Low of Dr Lal Pathlabs shares?

Dr Lal Pathlabs stock price high: Rs.2767.1 Dr Lal Pathlabs stock price low: Rs.1888.1
BUY
SELL